Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Commonly employed in research for designing drugs targeting neurological disorders and inflammatory conditions due to its ability to cross biological membranes and interact with central nervous system receptors. Also utilized in the preparation of receptor agonists and antagonists, especially in serotonin and dopamine pathways. Its trifluoromethyl and piperazine groups contribute to metabolic stability and improved pharmacokinetic profiles in drug candidates.